338 related articles for article (PubMed ID: 26398105)
1. GlycA, a Pro-Inflammatory Glycoprotein Biomarker, and Incident Cardiovascular Disease: Relationship with C-Reactive Protein and Renal Function.
Gruppen EG; Riphagen IJ; Connelly MA; Otvos JD; Bakker SJ; Dullaart RP
PLoS One; 2015; 10(9):e0139057. PubMed ID: 26398105
[TBL] [Abstract][Full Text] [Related]
2. GlycA, a novel pro-inflammatory glycoprotein biomarker is associated with mortality: results from the PREVEND study and meta-analysis.
Gruppen EG; Kunutsor SK; Kieneker LM; van der Vegt B; Connelly MA; de Bock GH; Gansevoort RT; Bakker SJL; Dullaart RPF
J Intern Med; 2019 Nov; 286(5):596-609. PubMed ID: 31260573
[TBL] [Abstract][Full Text] [Related]
3. A novel protein glycan biomarker and future cardiovascular disease events.
Akinkuolie AO; Buring JE; Ridker PM; Mora S
J Am Heart Assoc; 2014 Sep; 3(5):e001221. PubMed ID: 25249300
[TBL] [Abstract][Full Text] [Related]
4. GlycA, a marker of acute phase glycoproteins, and the risk of incident type 2 diabetes mellitus: PREVEND study.
Connelly MA; Gruppen EG; Wolak-Dinsmore J; Matyus SP; Riphagen IJ; Shalaurova I; Bakker SJ; Otvos JD; Dullaart RP
Clin Chim Acta; 2016 Jan; 452():10-7. PubMed ID: 26549655
[TBL] [Abstract][Full Text] [Related]
5. A novel protein glycan biomarker and LCAT activity in metabolic syndrome.
Gruppen EG; Connelly MA; Otvos JD; Bakker SJ; Dullaart RP
Eur J Clin Invest; 2015 Aug; 45(8):850-9. PubMed ID: 26081900
[TBL] [Abstract][Full Text] [Related]
6. Vitamin B6, Inflammation, and Cardiovascular Outcome in a Population-Based Cohort: The Prevention of Renal and Vascular End-Stage Disease (PREVEND) Study.
Minović I; Kieneker LM; Gansevoort RT; Eggersdorfer M; Touw DJ; Voerman AJ; Connelly MA; Boer RA; Hak E; Bos J; Dullaart RPF; Kema IP; Bakker SJL
Nutrients; 2020 Sep; 12(9):. PubMed ID: 32899820
[TBL] [Abstract][Full Text] [Related]
7. The association of novel inflammatory marker GlycA and incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis (MESA).
Jang S; Ogunmoroti O; Zhao D; Fashanu OE; Tibuakuu M; Benson EM; Norby F; Otvos JD; Heckbert SR; Szklo M; Michos ED
PLoS One; 2021; 16(3):e0248644. PubMed ID: 33765041
[TBL] [Abstract][Full Text] [Related]
8. GlycA: A New Biomarker for Systemic Inflammation and Cardiovascular Disease (CVD) Risk Assessment.
Ballout RA; Remaley AT
J Lab Precis Med; 2020 Apr; 5():. PubMed ID: 32363327
[TBL] [Abstract][Full Text] [Related]
9. Increase in the Inflammatory Marker GlycA over 13 Years in Young Adults Is Associated with Poorer Cognitive Function in Midlife.
Cohen-Manheim I; Doniger GM; Sinnreich R; Simon ES; Pinchas-Mizrachi R; Otvos JD; Kark JD
PLoS One; 2015; 10(9):e0138036. PubMed ID: 26406330
[TBL] [Abstract][Full Text] [Related]
10. Soluble urokinase plasminogen activator receptor in plasma is associated with incidence of CVD. Results from the Malmö Diet and Cancer Study.
Persson M; Engström G; Björkbacka H; Hedblad B
Atherosclerosis; 2012 Feb; 220(2):502-5. PubMed ID: 22119508
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality. A population-based, prospective study.
Tuomisto K; Jousilahti P; Sundvall J; Pajunen P; Salomaa V
Thromb Haemost; 2006 Mar; 95(3):511-8. PubMed ID: 16525580
[TBL] [Abstract][Full Text] [Related]
12. Association of plasma aldosterone with cardiovascular mortality in patients with low estimated GFR: the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study.
Tomaschitz A; Pilz S; Ritz E; Grammer T; Drechsler C; Boehm BO; März W
Am J Kidney Dis; 2011 Mar; 57(3):403-14. PubMed ID: 21186074
[TBL] [Abstract][Full Text] [Related]
13. Prospective associations between hsCRP and GlycA inflammatory biomarkers and depression: The Brazilian longitudinal study of adult health (ELSA-Brasil).
Brunoni AR; Salum GA; Hoffmann MS; Goulart AC; Barreto SM; Canhada S; Carvalho AF; Koyanagi A; Calice-Silva V; Lotufo PA; Santos IS; Suemoto CK; Benseñor IM
J Affect Disord; 2020 Jun; 271():39-48. PubMed ID: 32312696
[TBL] [Abstract][Full Text] [Related]
14. Low grade inflammation as measured by levels of YKL-40: association with an increased overall and cardiovascular mortality rate in an elderly population.
Rathcke CN; Raymond I; Kistorp C; Hildebrandt P; Faber J; Vestergaard H
Int J Cardiol; 2010 Aug; 143(1):35-42. PubMed ID: 19223085
[TBL] [Abstract][Full Text] [Related]
15. GlycA, a biomarker of inflammatory glycoproteins, is more closely related to the leptin/adiponectin ratio than to glucose tolerance status.
Dullaart RP; Gruppen EG; Connelly MA; Otvos JD; Lefrandt JD
Clin Biochem; 2015 Aug; 48(12):811-4. PubMed ID: 25977069
[TBL] [Abstract][Full Text] [Related]
16. Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events.
Mora S; Rifai N; Buring JE; Ridker PM
Circulation; 2006 Aug; 114(5):381-7. PubMed ID: 16864722
[TBL] [Abstract][Full Text] [Related]
17. Association of the Novel Inflammatory Marker GlycA and Incident Heart Failure and Its Subtypes of Preserved and Reduced Ejection Fraction: The Multi-Ethnic Study of Atherosclerosis.
Jang S; Ogunmoroti O; Ndumele CE; Zhao D; Rao VN; Fashanu OE; Tibuakuu M; Otvos JD; Benson EM; Ouyang P; Michos ED
Circ Heart Fail; 2020 Aug; 13(8):e007067. PubMed ID: 32762458
[TBL] [Abstract][Full Text] [Related]
18. Plasma levels of GlycA, a pro-inflammatory glycoprotein biomarker, associate with an increased risk of microvascular complications in patients with type 2 diabetes (Zodiac-62).
Bourgonje AR; van der Vaart A; Gruppen EG; van Goor H; Bakker SJL; Connelly MA; van Dijk PR; Dullaart RPF
Endocrine; 2023 May; 80(2):312-316. PubMed ID: 36757630
[TBL] [Abstract][Full Text] [Related]
19. A pro-inflammatory glycoprotein biomarker is associated with lower bilirubin in metabolic syndrome.
Dullaart RP; Gruppen EG; Connelly MA; Lefrandt JD
Clin Biochem; 2015 Nov; 48(16-17):1045-7. PubMed ID: 26129880
[TBL] [Abstract][Full Text] [Related]
20. HDL (High-Density Lipoprotein) Cholesterol Efflux Capacity Is Associated With Incident Cardiovascular Disease in the General Population.
Ebtehaj S; Gruppen EG; Bakker SJL; Dullaart RPF; Tietge UJF
Arterioscler Thromb Vasc Biol; 2019 Sep; 39(9):1874-1883. PubMed ID: 31315436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
